Home‐Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021–2022—A Pilot Study
Home-based swabbing was feasible and acceptable. We were able to calculate an influenza VE, although a larger sample size and verification of vaccine status may improve the VE estimates in the future.
Authors
- Cherie Cawood (ORCID: https://orcid.org/0000-0002-5031-2518)
- Gillian Hunt (ORCID: https://orcid.org/0000-0001-8933-0628)
- Phiwokuhle Ntombela
- Jocelyn Moyes (ORCID: https://orcid.org/0000-0001-8040-1717)
- Anne von Gottberg (ORCID: https://orcid.org/0000-0002-0243-7455)
- Erica Dueger (ORCID: https://orcid.org/0000-0001-6404-3163)
- Mignon du Plessis (ORCID: https://orcid.org/0000-0001-9186-0679)
- Sibongile Walaza (ORCID: https://orcid.org/0000-0001-7588-2480)
- Fahima Moosa (ORCID: https://orcid.org/0000-0003-0281-3649)
- Cheryl Cohen (ORCID: https://orcid.org/0000-0003-0376-2302)
- Nicole Wolter (ORCID: https://orcid.org/0000-0001-5623-7101)
- Mvuyo Makhazi
Institutions
- National Health Laboratory Service (ZA)
- University of the Witwatersrand (ZA)
- Sanofi (France) (FR)
- Epicentre (South Africa) (ZA)
Publication Details
- Journal
- Influenza and Other Respiratory Viruses
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1111/irv.70034
- Citations
- 2
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Bill and Melinda Gates Foundation
- Sanofi
- Centers for Disease Control and Prevention